- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03040609
Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision) (PLH-Vision)
The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities.
The secondary objectives of the study are:
- to validate the structure of the scale.
- to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
- to evaluate the feasibility of visio-behavioral scale.
- to evaluate the sensitivity to change.
- to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
- to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.
Study Overview
Status
Conditions
Detailed Description
This study includes 3 phases:
- Elaboration of a list of behavioral items by a group of multi-disciplinary expertise (physicians, nurses, caregivers, ophthalmologies, orthoptists) based on their clinical experiences.
- Development of the scale based on the sample obtained by a prospective multicenter research trial.
- Validation of the sample obtained by a prospective transversal multicenter study.
This study will be performed in 5 centers in France. The enrollment of patients planned for 24 months targeting 310 patients. The duration of follow-up of the study for each patient will be varied according to the group of patients, il will be 1 day for group 1, 2 weeks for group 2, or 6 months for group 3.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Var
-
Hyères, Var, France, 83407
- Hôpital San Salvadour
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Causal brain injury occurred before the age of 3 years.
- Severe or deep mental retardation as defined by DSM IV.
- Motor impairment: para / tetraparesis, hemiparesis, ataxia, or extrapyramidal motor disorders.
- Score of Gross Motor Function Classification System [Palisano 1997] is III, IV or V.
- Score of Functional Independence Measure < 55.
- Subject aged ≥3 years (because the visio-behavioral scale is not adapted for children younger than 3 years).
- Beneficiary of a social protection.
- Written consent signed by guardian or legal representative, or parents in case of a minor subject.
Exclusion Criteria:
- Acute intercurrent pathology precluding examinations.
- Patient with hypersensitivity to tropicamide, atropine or benzalkonium chloride.
- Angle closure glaucoma suspect patient.
- Patient with severe hypertension.
- Short life expectancy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
The duration of follow-up of group 1 in the study is 1 day.
|
To perform the classification with the scale by caregiver.
To perform the classification with the scale by orthoptist at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end 6 months.
|
|
Group 2
The duration of follow-up of group 2 in the study is 2 weeks.
|
To perform the classification with the scale by orthoptist at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end 6 months.
|
|
Group 3
The duration of follow-up of group 3 in the study is 6 months.
|
To perform the classification with the scale by orthoptist at the end 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concordance of classification
Time Frame: throughout the study: 31 months
|
Statistical analysis: concordance between the classification obtained by caregiver with the scale, and the classification obtained by orthoptist-ophthalmology.
|
throughout the study: 31 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Structure of the scale
Time Frame: throughout the study: 31 months
|
Statistical analysis to validate the structure of the scale.
|
throughout the study: 31 months
|
|
Reproducibility of scale
Time Frame: throughout the study: 31 months
|
Statistical analysis to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
|
throughout the study: 31 months
|
|
Feasibility of visio-behavioral scale
Time Frame: throughout the study: 31 months
|
Statistical analysis to evaluate by the proportion of patients who have the complet examination, the average of time to all examens, the tolerance data. feasibility of visio-behavioral scale. |
throughout the study: 31 months
|
|
Sensitivity to change
Time Frame: throughout the study: 31 months
|
Statistical analysis to evaluate the sensitivity to change.
|
throughout the study: 31 months
|
|
Uniformity of use of the scale
Time Frame: throughout the study: 31 months
|
Statistical analysis to assess the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
|
throughout the study: 31 months
|
|
Prevalence of the visual disorder
Time Frame: throughout the study: 31 months
|
Statistical analysis to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.
|
throughout the study: 31 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Marie-Christine ROUSSEAU, MD, AP-HP, Hôpital San Salvadour, 83407 Hyères
- Study Chair: Soizic CHARBONNIER, Orthoptist, Cabinet du Lycée
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P140712
- RCB: 2016-A00278-43 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Profound Multiple Intellectual Disabilities
-
University of Wisconsin, MadisonPatient-Centered Outcomes Research InstituteNot yet recruitingDevelopmental Disability | Intellectual DisabilitiesUnited States
-
Temple UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Enrolling by invitationIntellectual and Developmental DisabilityUnited States
-
University of HaifaRecruitingIntellectual Disabilities Global Developmental DelayIsrael
-
Instituto Politécnico de LeiriaCompleted
-
Cairo UniversityCompletedDisabilities MultipleEgypt
-
Ankara Yildirim Beyazıt UniversityUnknownDisabilities MultipleTurkey
-
Vestvagoy MunicipalityUniversity of Oslo; University of TromsoActive, not recruitingDisability, Developmental | Disabilities, IntellectualNorway
-
Rush University Medical CenterUniversity of Minnesota; St. John Fisher CollegeRecruitingDisabilities MultipleUnited States
-
University of GöttingenCompletedIntellectual and/or Physical Disabilities | Dental Treatment Under General Anesthesia
-
University of ExtremaduraUniversity of CadizCompletedDisability Physical | Disabilities Multiple | Disability, Intellectual | Disability Hearing | Disability, VisionSpain
Clinical Trials on Visual-behavioral Scale at day 1
-
Centre d'Etudes et de Recherche pour l'Intensification...Suspended
-
Sinovac Research and Development Co., Ltd.Completed
-
Fatih Sultan Mehmet Training and Research HospitalCompleted
-
Recep Tayyip Erdogan University Training and Research...CompletedDental Anxiety | Anxiety Disorder | AromatherapyTurkey
-
Turku University HospitalUniversity of TurkuCompletedDepression | Sleep Disturbance | Prolonged PregnancyFinland
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
Fundación Santiago Dexeus FontOrganonCompleted
-
Poitiers University HospitalCompleted
-
Pleryon Therapeutics (Hangzhou) LimitedUniversity of Waterloo School of Optometry and Vision ScienceRecruiting
-
Hospices Civils de LyonRecruitingHealthy Volunteers | Mild ConcussionFrance